CIRBP Family, Tumors, Molecular Mechanisms, RNA-Binding Proteins, Cellular Stress Share and Cite: Cai, Y. , Wang, T. and Zhan ...
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...
Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.
The firm will study its autologous cell therapy alone and in combination with Eisai's Lenvima in patients with hepatitis B-driven hepatocellular carcinoma.
The FDA has approved Adcetris (brentuximab vedotin) for use in combination with lenalidomide and rituximab to treat patients with relapsed/refractory LBCL after 2 or more lines of systemic therapy who ...
Bailey Hutchins — a registered nurse who harnessed her two-year battle with Stage 4 colorectal cancer to inspire hundreds of ...
A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the ...